Raymond James & Associates’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-7,802
| Closed | -$76K | – | 3375 |
|
|
2017
Q2 | $76K | Buy |
7,802
+967
| +14% | +$9.42K | ﹤0.01% | 3097 |
|
|
2017
Q1 | $166K | Buy |
6,835
+1,209
| +21% | +$29.4K | ﹤0.01% | 2948 |
|
|
2016
Q4 | $181K | Sell |
5,626
-318
| -5% | -$10.2K | ﹤0.01% | 2880 |
|
|
2016
Q3 | $297K | Buy |
5,944
+254
| +4% | +$12.7K | ﹤0.01% | 2614 |
|
|
2016
Q2 | $241K | Sell |
5,690
-241
| -4% | -$10.2K | ﹤0.01% | 2531 |
|
|
2016
Q1 | $391K | Buy |
5,931
+1,546
| +35% | +$102K | ﹤0.01% | 2181 |
|
|
2015
Q4 | $273K | Sell |
4,385
-877
| -17% | -$54.6K | ﹤0.01% | 2221 |
|
|
2015
Q3 | $352K | Sell |
5,262
-191
| -4% | -$12.8K | ﹤0.01% | 2073 |
|
|
2015
Q2 | $530K | Buy |
5,453
+725
| +15% | +$70.5K | ﹤0.01% | 2063 |
|
|
2015
Q1 | $442K | Buy |
+4,728
| New | +$442K | ﹤0.01% | 2085 |
|